Calculus has led an investment round into Laverock Therapeutics, a company developing a unique gene silencing platform for the creation of programmable advanced therapies.
Wonderhood Studios continue their stellar performance of signing household names as clients as part of their advertising business.
Maven Screen Media and Brouhaha continue progress.
Scancell achieve significant milestone for their cancer vaccine.
Calculus is delighted to launch the Calculus EIS Fund offering an opportunity to invest in entrepreneurial businesses with growth potential, across the fast growing sectors of technology and healthcare.
Arecor’s subsidiary Tetris Pharma have a signed an agreement with Goodlife.
Arecor to partner with a Top 10 Pharma to develop an enhanced antibody formulation for one of its investigational drugs.